{
    "clinical_study": {
        "@rank": "154750", 
        "brief_summary": {
            "textblock": "The purpose of the study is to assess the effect of progressive, incremental hypoxia at\n      multiple wavelengths of light."
        }, 
        "brief_title": "Hypoxia at Multiple Wavelengths of Light", 
        "completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "condition": "Hypoxia in Healthy Individuals", 
        "condition_browse": {
            "mesh_term": "Anoxia"
        }, 
        "detailed_description": {
            "textblock": "No additional information is required."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Is between 18 and 35 years of age\n\n          -  Is American Society Anesthesiologist status 1\n\n          -  Has a BMI between 18 and 30\n\n        Exclusion Criteria:\n\n          -  Currently taking any medications other than birth control pills\n\n          -  Has participate in an investigational drug study within one month prior to  the start\n             of the study\n\n          -  Fails the Allen's Test to confirm patency of the colateral artery\n\n          -  Subject is female with a positive pregnancy test, or is female and is unwilling to\n             use effective birth control between the time of screening and study termination\n\n          -  Has a positive urine continine or drug test\n\n          -  Has an reported allergy to Lidocaine\n\n          -  Has anemia or other hemoglobinopathy\n\n          -  Has a room air saturation less than 95% by pulse oximetry\n\n          -  Has an abnormal EKG\n\n          -  Has an abnormal pulmonary function test via spirometry\n\n          -  Is intolerant to a breathing mask apparatus\n\n          -  Has a COHb greater than 3%, or MetHb greater than 2%\n\n          -  Has another condition, which in the opinion of the principle investigator would not\n             be suitable for participation in the study\n\n          -  Is unwilling or unable to provide informed consent or comply with the study\n             procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "35 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Healthy volunteers"
            }
        }, 
        "enrollment": {
            "#text": "26", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01957891", 
            "org_study_id": "QATP2552"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hypoxia", 
            "Multiple wavelengths"
        ], 
        "lastchanged_date": "March 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Durham", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27710"
                }, 
                "name": "HPPL Duke Univeristy"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Effect of Induced Hypoxia at Multiple Wavelengths", 
        "overall_official": {
            "affiliation": "Duke University", 
            "last_name": "David MacLeod, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Assess the effect of progressive, incremental hypoxia at multiple wavelengths of light", 
            "safety_issue": "No", 
            "time_frame": "Up to 8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01957891"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Nonin Medical, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Nonin Medical, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}